<p>Using the propensity-matched methodology, this meta-analysis and comprehensive review aimed to compare robotic distal pancreatectomy with laparoscopic distal pancreatectomy in terms of perioperative and short-term oncologic outcomes. Within the scope of this investigation, complete and total adherence to the PRISMA guidelines for Systematic Reviews and Meta-Analyses was established. The search we conducted in PubMed, Google Scholar, and EMBASE was automated to find relevant papers that matched the tendency up to July 1, 2024. The length of time spent while operating, the rate of conversion, and the collection of lymph nodes were the primary factors that were considered. Other metrics that were taken into consideration were the approximate amount of blood loss, the length of time spent in the hospital, the need for transfusions, and the occurrence of major adverse events. In the end, there were 8 studies that involved 1649 patients. Of those patients, 758 had robotic assisted distal pancreatectomy, whereas 891 underwent laparoscopic distal pancreatectomy. In comparison to laparoscopic distal pancreatectomy, the robotic assisted technique did result in higher anticipated blood loss and conversion rates; however, it also required longer durations of operation due to its lengthier duration. In terms of lymph node retrieval, the duration of hospital stay, the need for blood transfusions, and the incidence of postoperative pancreatic fistula, there were no distinctions that could be considered statistically significant between the two techniques. A realistic and risk-free surgical alternative is a distal pancreatectomy that is performed with the aid of robotic technology. When compared to laparoscopic surgery, the outcomes of robot-assisted surgery were superior in terms of conversion rates to laparotomy and less anticipated intraoperative blood loss. However, the operation took longer to complete than laparoscopic surgery.</p>